PRESS RELEASE published on 08/02/2024 at 07:30, 3 months 19 days ago EUROBIO SCIENTIFIC FINALISE L’ACQUISITION DU TEST GÉNOMIQUE ENDOPREDICT® AUPRÈS DE MYRIAD GENETICS Eurobio Scientific finalise l’acquisition du test génomique EndoPredict® auprès de Myriad Genetics, renforçant son leadership dans le diagnostic médical in vitro. Pour plus d'informations, visitez www.eurobio-scientific.com Diagnostic Médical Eurobio Scientific Myriad Genetics Test Génomique EndoPredict®
BRIEF published on 07/31/2024 at 21:08, 3 months 20 days ago EUROBIO SCIENTIFIC : Accord d'offre publique d'achat volontaire Offre Publique D'achat Diagnostic In Vitro Eurobio Scientifique Partenaires CI Étape Suivante AM
BRIEF published on 07/31/2024 at 21:08, 3 months 20 days ago EUROBIO SCIENTIFIC: Agreement for a Voluntary Tender Offer In Vitro Diagnostics Tender Offer Eurobio Scientific IK Partners NextStage AM
BRIEF published on 07/31/2024 at 21:06, 3 months 20 days ago Eurobio Scientific : Un premier semestre 2024 robuste dans un contexte d'incertitude Offre Publique D'achat Acquisitions Hausse Des Revenus Eurobio Scientifique Produits Exclusifs
BRIEF published on 07/31/2024 at 21:06, 3 months 20 days ago Eurobio Scientific: Robust First Half of 2024 Amid Uncertainty Revenue Growth Acquisitions Tender Offer Eurobio Scientific Proprietary Products
PRESS RELEASE published on 07/31/2024 at 21:03, 3 months 20 days ago EUROBIO SCIENTIFIC: CONCLUSION OF AN AGREEMENT BETWEEN EUROBIO SCIENTIFIC AND A CONSORTIUM LED BY EUROBIO SCIENTIFIC'S TEAM OF ENTREPRENEURS AND MANAGERS, IK PARTNERS AND NEXTSTAGE AM WITH A VIEW TO FILE A VOLUNTARY TENDER OFFER AT A PRICE Eurobio Scientific announces a voluntary tender offer at €25.30 per share led by a consortium including NextStage AM and IK Partners, aiming at accelerating the company's growth plan Voluntary Tender Offer Consortium Eurobio Scientific IK Partners NextStage AM
PRESS RELEASE published on 07/31/2024 at 21:01, 3 months 20 days ago Eurobio Scientific : PREMIER SEMESTRE 2024, UN SOLIDE DEBUT D’EXERCICE DANS UN CONTEXTE INCERTAIN // PROJET D’OFFRE PUBLIQUE Eurobio Scientific, groupe leader français du diagnostic médical in vitro et des sciences de la vie, annonce une solide croissance de +24% de son chiffre d'affaires semestriel au 1er semestre 2024 Chiffre D'affaires Croissance Offre Publique Diagnostic Médical Eurobio Scientific
PRESS RELEASE published on 07/31/2024 at 21:01, 3 months 20 days ago Eurobio Scientific: FIRST HALF 2024, A SOLID START TO THE FINANCIAL YEAR IN AN UNCERTAIN ENVIRONMENT // PROPOSED TENDER OFFER Eurobio Scientific reports a strong start to the financial year with a +24% revenue growth in H1 2024. Proposed tender offer led by consortium for voluntary shares acquisition Revenue Growth Tender Offer Consortium H1 2024 Eurobio Scientific
BRIEF published on 07/23/2024 at 11:35, 3 months 29 days ago Eurobio Scientific : calendrier des publications financières du deuxième semestre 2024 Calendrier Financier Bourse Diagnostic Médical Publications 2024 Eurobio Scientific
BRIEF published on 07/23/2024 at 11:35, 3 months 29 days ago Eurobio Scientific: calendar of financial publications for the second half of 2024 Financial Calendar Sotck Exchange Medical Diagnosis Publications 2024 Eurobio Scientific
Published on 11/21/2024 at 12:00, 45 minutes ago Alset AI Announces Full Repayment of $3.7 Million Secured Loan with Interest from Portfolio Company, Significantly Strengthening Balance Sheet
Published on 11/21/2024 at 12:00, 45 minutes ago Battery X Metals Commences Strategic Initiatives to Strengthen Balance Sheet
Published on 11/21/2024 at 11:30, 1 hour 15 minutes ago FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 2 hours 42 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 2 hours 45 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 12:35, 10 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 30 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 11:30, 1 hour 15 minutes ago APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 06:58, 5 hours 47 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 47 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 47 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 16 hours 37 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 25 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting